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The aim of this study was to analyze whether snoring and excessive daytime sleepiness
(EDS), the main symptoms of obstructive sleep apnea syndrome (OSAS), are associated
with hypertension and diabetes in women. A random sample of 6779 women aged 20–99
years answered questionnaires on sleep disturbances, daytime symptoms and somatic
diseases. The women were categorized into four groups: ‘‘no EDS or snoring’’ (reference
group), ‘‘snoring but no EDS’’, ‘‘EDS but no snoring’’ and ‘‘snoring and EDS’’. Prevalences of
hypertension and diabetes were lowest in the reference group (8.7% and 1.6%,
respectively) and highest among women with both snoring and EDS (hypertension:
26.3%, diabetes: 5.8%). In a multivariate model adjusting for age, body mass index,
smoking, physical activity and alcohol dependency, ‘‘snoring and EDS’’ was a risk factor for
hypertension (adjusted OR 1.82 (95% CI 1.30–2.55)) while isolated snoring or EDS was not.
‘‘Snoring and EDS’’ was more closely related to hypertension among women aged o50
years (adj. OR 3.41 (1.78–6.54) vs. 1.50 (1.02–2.19), P ¼ 0.01). For diabetes, both ‘‘EDS
but no snoring’’ and ‘‘snoring and EDS’’ were risk factors and the associations were most
pronounced in women aged450 years (adj. OR 2.33 (1.28–4.26) for ‘‘EDS but no snoring’’
and 2.00 (1.05–3.84) for ‘‘snoring and EDS’’). We conclude that the combination of snoring
and EDS is a risk factor for hypertension and diabetes in women. For hypertension, the risk
is partly age dependent and, for diabetes, EDS without snoring is a risk factor of similarElsevier Ltd. All rights reserved.
611 40 61; fax: +46 18 611 28 19.
emiska.se (E. Lindberg).
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E. Lindberg et al.1284magnitude. These differences might indicate differences in pathophysiologic mechanisms
underlying the association between sleep-disordered breathing and hypertension and
diabetes respectively.
& 2006 Elsevier Ltd. All rights reserved.Symptom groups:
Snoring but no EDS     EDS but no snoring
(n=1,438)        (n=580) 
No EDS or snoring Snoring and EDS
(reference group, (n=293)
n=4,468) 
Total population, n=6,779 
Reported snoring Reported EDS
Figure 1 Approach applied to categorize the population when
analyzing the risk factors for hypertension and diabetes. The
percentage of subjects within each circle represents those who
reported snoring and EDS, respectively. Subjects without
snoring and EDS were used as a reference group.Introduction
Hypertension and type 2 diabetes are two components of the
metabolic syndrome. Apart from well-known risk factors, such
as obesity, physical inactivity and excessive alcohol intake,
there are also data indicating that both disorders are related
to the obstructive sleep apnea syndrome (OSAS).1–4
The hypothesis that OSAS is causally related to hyperten-
sion and diabetes is supported by the fact that the successful
treatment of OSAS is followed by a reduction in blood
pressure2,5 and an improvement in insulin sensitivity.6 The
underlying pathophysiologic mechanisms are not fully under-
stood, but it can be speculated that hypoxemia, hypercapnia
and/or arousal from sleep, followed by the chronic activation
of the sympathetic nervous system,7 negatively influence the
metabolic and cardiovascular system. Whether negative
effects on blood pressure and glucose metabolism caused
by obstructive sleep apnea share similar pathophysiologic
mechanisms or have different pathways remains unclear.
Snoring is one of the cardinal symptoms of OSAS. Several
studies have found that snoring is positively associated with
both hypertension8–12 and diabetes.13,14 It seems reasonable
that snoring increases the risk of hypertension and diabetes
through OSAS, but most snorers do not have sleep apnea.15
Furthermore, some studies have failed to confirm snoring as
an independent risk factor when age and overweight have
been adjusted for.16–18 Despite the fact that daytime
symptoms are mandatory for the diagnosis of OSAS,19 most
previous studies of snoring and somatic disease have been
performed without taking daytime sleepiness, into account.
The aim of this study was to analyze whether snoring and
excessive daytime sleepiness (EDS), or a combination of
both, are risk factors for hypertension and diabetes in a
population-based sample of women.
Methods
Population
A random sample of 10,000 women aged 20 years or more
living in the city of Uppsala, Sweden, was drawn from the
population registry. As 14 of the women had died and 144 had
moved to unknown addresses the final target population was
9842 women. A postal questionnaire was sent in April 2000,
followed by reminders after 1 and 2 months, respectively.
The study population comprised the 6779 subjects who
returned completed questionnaires, including the questions
on snoring and daytime sleepiness (response rate 68.9%).
Questionnaire
The questionnaire consisted of 109 questions on snoring,
sleep disturbances, daytime symptoms and medical dis-orders. Body mass index (BMI) was calculated from self-
reported height and weight. For questions regarding
symptoms related to sleep disturbances, the subjects were
asked how often they experienced specific symptoms using a
five-point scale: 1 ¼ never, 2 ¼ seldom, 3 ¼ sometimes,
4 ¼ often and 5 ¼ very often. In the question about snoring,
the subjects were asked to state the frequency of their
‘‘loud and disturbing snoring’’. Daytime sleepiness was
assessed using the question ‘‘How often do you fall asleep
involuntarily for a short period during the day, for example,
when there is a pause at work?’’. Snoring and EDS were
defined as a score of 3–5.20 Women were categorized into
four groups of snoring and EDS according to Fig. 1.21
The subjects were asked if they had ever smoked
regularly for 46 months and if they were current smokers
or ex-smokers. They were asked the age at which they had
started to smoke and when they had quit. Ex-smoking was
considered if they had stopped smoking 46 months before
inclusion. Alcohol dependency was defined as at least
two positive answers to the cut down, annoyed by
criticism, guilty about drinking, eye-opener drinks (CAGE)
questionnaire.22,23
The level of physical activity during leisure time was
categorized into three groups. A low level of physical
activity was defined as spending most of one’s time in front
of the television, reading or engaging in other sedentary
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physical activity like cycling or walking to work for at least
4 h a week was reported. A high level included regular
physical activity like swimming, jogging, tennis, aerobic
exercise for at least 3 h a week or even more vigorous
activities on a weekly basis. The categorization was adopted
from a large population-based, prospective study on
physical activity and mortality in women.24
Three general questions were included about regular
medical examinations, previous hospital care and medica-
tion. The subjects were classified as having hypertension if
they reported attending regular medical examinations for
hypertension and/or answered ‘‘Yes’’ to the question: ‘‘Do
you have high blood pressure?’’. Similarly, those who
answered ‘‘Yes’’ to the question ‘‘Do you have diabetes?’’
and/or said that they attended regular medical examina-
tions for diabetes were classified as having diabetes.
The informed consent of all participants was obtained and
the study was approved by the Ethics Committee at the
Medical Faculty at Uppsala University.Statistical analysis
Statistical analyses were performed using Statviews 5.0
(SAS Institute; Cary, NC, USA) and Statas 8.0 (Stata
Corporation, College Station, TX). The results are presented
as the means 7SD. The w2 test was used to test for
differences between proportions. When the comparison
involved continuous variables, the Mann–Whitney U-test
was used. Multiple logistic regression analysis was per-
formed for simultaneous evaluations of more than two
variables and the results are expressed as odds ratios (OR)
with 95% confidence intervals (CI). To analyze the indepen-Table 1 Characteristics of the participants by symptom group
No EDS or snoring
(n ¼ 4468)
EDS but no snoring
(n ¼ 580)
S
(
Age 42.2716.8 45.0722.0 5
BMI (kg/m2) 23.473.6 23.773.7 2
BMI430 (kg/m2) 231 (5.2) 34 (5.9) 2
Alcohol
dependency
253 (5.8) 42 (7.7) 6
Physical activity
Low level 575 (13.0) 103 (18.1) 2
Intermediate
level
2867 (64.7) 340 (59.9) 9
High level 986 (22.3) 125 (22.0) 1
Smoking status
Non-smoker 2841 (63.9) 399 (69.9) 7
Ex-smoker 937 (21.1) 96 (16.8) 3
Current smoking 667 (15.0) 76 (13.3) 3
The results are presented as mean+SD or as n (%a). P-values calculate
Po0.05.
Po0.01.
Po0.001.
aPercentage of those who responded to the actual question.dent influence of EDS and snoring on the somatic diseases,
multivariate models were used, with adjustment for age,
BMI, alcohol dependency, level of physical activity and
smoking status. Multiple logistic regression analyzes were
performed for the whole group and also for the younger
(ageo50 years) and older (450 years) groups separately.
Age was categorized into 10-year intervals in the multiple
analysis, while BMI was categorized into four intervals (o20,
20–o25, 25–o30 and X30 kg/m2). The null hypothesis was
rejected at the 5% level (Pp0.05).
Results
The mean age of the 6779 respondents was 44.7717.2 years
(range 20–99 years). Snoring was reported by 1731 subjects
(25.2%) and EDS by 873 (12.9%). EDS was more common
among snorers than among non-snorers (16.9 vs. 11.5%,
Po0.001) and a total of 293 women (4.3%) suffered from
both snoring and EDS (Fig. 1). Subjects with EDS and/or
snoring were generally older, more frequently obese and less
physically active compared with non-snoring women without
EDS, whereas the prevalence of alcohol dependency did not
differ significantly. Subjects reporting EDS but not snoring
were more often non-smokers, while snorers without EDS
were more often smokers (Table 1).
Hypertension and diabetes
Of the total population, 763 women (11.3%) fulfilled the
criteria for hypertension and 157 (2.4%) the criteria for
diabetes. A total of 67 females (1.0%) suffered from both
hypertension and diabetes. Both hypertension and diabetes
were strongly age dependent (Fig. 2)..
noring but no EDS
n ¼ 1438)
Snoring and EDS
(n ¼ 293)
Total (n ¼ 6779)
0.2713.9 55.3717.8 44.7717.2
5.874.7 26.475.0 24.174.1
29 (16.0) 55 (19.0) 549 (8.2)
8 (4.9) 14 (5.1) 377 (5.8)
63 (18.5) 61 (21.2) 1335 (19.9)
65 (67.9) 196 (68.1) 4368 (65.1)
93 (13.6) 31 (10.8) 1335 (19.9)
05 (49.5) 165 (57.3) 4110 (61.1)
81 (26.7) 60 (20.8) 1474 (21.9)
39 (23.8) 63 (21.9) 1145 (17.0)
d for differences compared with subjects with no symptoms.
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Figure 2 Prevalence of hypertension and diabetes by age group.
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Figure 3 Prevalence of hypertension and diabetes by symptom
group. **Po0.01, ***Po0.001. P-values indicate differences
compared to the reference group with no EDS or snoring.
E. Lindberg et al.1286The lowest prevalences of both hypertension and diabetes
were found among women who reported neither snoring nor
EDS (Fig. 3). In this reference group, the prevalence of
hypertension was 8.7%. Of the subjects reporting EDS but
not snoring, 12.8% had hypertension (P ¼ 0.0015 when
compared with the reference group), while the correspond-
ing figure for the snorers without EDS was 15.5%
(Po0.0001). The highest prevalence of hypertension was
found among females who reported both snoring and EDS,
26.3% of whom suffered from hypertension (Po0.0001).
For reported diabetes, the prevalence in women without
EDS or snoring was 1.6%, increasing to 5.0% in the group with
EDS but no snoring (Po0.0001 compared with the reference
group). In addition, snoring women without EDS had a higher
prevalence of diabetes (2.9%, P ¼ 0.0008) and the highest
prevalence was found when EDS and snoring occurred
together (5.8%, Po0.0001).
Several of the risk factors for EDS and snoring (Table 1)
were also more common among women with hypertension
and diabetes. Both diseases were associated with higher
age, obesity and physical inactivity (Table 2).Risk factor for hypertension
In the whole study population, the most prominent
independent risk factor for hypertension was obesity,
defined as BMIX30 kg/m2 (Table 3). The combination of
both EDS and snoring was the second most important risk
factor with an adjusted OR of 1.82 (95% CI 1.30–2.55).
Neither EDS without snoring nor snoring without EDS was
significantly related to hypertension. Alcohol dependency
and a low level of physical activity were also significant risk
factors for hypertension, while smoking was not.
The combination of EDS and snoring was significantly
associated with hypertension in both the younger and the
older age group. However, the adjusted OR was significantly
higher among women agedo50 years than among the older
women (3.41 (95% CI 1.78–6.54) vs. 1.50 (95% CI 1.02–2.19),
P ¼ 0.01). Isolated snoring or EDS was not related to
hypertension in any of the age groups. In the younger age
group there was further a significant interaction between
‘‘snoring and EDS’’ and BMI430 kg/m2 (adj. OR 6.3, 95% CI
1.02–39.10), while there were no other significant interac-
tions between BMI and snoring, EDS or ‘‘snoring and EDS’’,
respectively. Alcohol dependency was only a predictor of
hypertension in younger women, while a low level of
physical activity was only significantly related to hyperten-
sion in women 450 years.
Risk factors for diabetes
Obesity was an independent risk factor for diabetes. Of the
symptom groups, only EDS without snoring was significantly
related to diabetes in the whole population (adjusted OR
2.11 (95% CI 1.22–3.66)). For the combination of EDS and
snoring, the adjusted OR was of a similar magnitude (adj. OR
1.82), but the association did not reach statistical signifi-
cance (95% CI 0.97–3.43) (Table 4).
Only 23 subjects among women o50 years reported
diabetes. Eleven were on insulin therapy, one on oral anti-
diabetic drugs and 11 did not report any medication at all.
None of these diabetic women had reported the combina-
tion of snoring and EDS, while five reported snoring and
three EDS. Diabetes in the younger age group was not
significantly related to any of the studied risk factors. In the
older age group aged X50 years, both EDS without snoring
and the combination of EDS and snoring were significantly
associated with the risk of diabetes. Among the other
studied risk factors, only obesity was significantly associated
with diabetes in the older age group. For diabetes there
were no significant interactions between BMI and Snoring,
EDS or ‘‘snoring and EDS’’.
The multiple logistic regression analyses were repeated
when only the 4.525 women (67%) who had answered ‘‘Yes’’
to the question ‘‘Do you share a bedroom with another
person?’’ were included. The results did not change
significantly from the results presented in Tables 3–4 (data
not shown).
Discussion
This is the first epidemiologic study in women designed
to analyze how sleep-disordered breathing (snoring) is
ARTICLE IN PRESS
Table 3 Risk factors for hypertension in a population-based sample of women.
All subjects (n ¼ 6200) o50 years (n ¼ 3888) 4 50 years (n ¼ 2312)
BMIo20 (kg/m2) 0.76 (0.51–1.13) 0.95 (0.52–1.76) 0.64 (0.38–1.09)
20–o25 (kg/m2) 1 1 1
25–o30 (kg/m2) 1.79 (1.47–2.18) 2.09 (1.38–3.16) 1.69 (1.35–2.12)
430 (kg/m2) 3.00 (2.29–3.93) 2.99 (1.73-5.16) 3.00 (2.19-4.10)
Alcohol dependency 1.86 (1.23–2.80) 2.02 (1.20–3.40) 1.59 (0.82–3.09)
Physical activity
High level 1 1 1
Intermediate level 1.17 (0.87–1.58) 0.92 (0.59–1.41) 1.44 (0.94–2.20)
Low level 1.48 (1.04–2.09) 1.12 (0.64–1.94) 1.84 (1.14–2.96)
Smoking status
Non-smoker 1 1 1
Ex-smoker 0.99 (0.80–1.23) 0.94 (0.59–1.41) (0.79–1.27)
Current smoking 1.04 (0.81–1.34) 1.12 (0.64–1.94) 0.93 (0.69–1.27)
EDS and snoring
No EDS or snoring 1 1 1
EDS but no snoring 1.08 (0.78–1.49) 1.24 (0.66–2.32) 1.00 (0.69–1.47)
Snoring but no EDS 1.12 (0.91–1.38) 1.04 (0.66–1.65) 1.13 (0.89–1-43)
Snoring and EDS 1.82 (1.30–2.55) 3.41 (1.78–6.54) 1.50 (1.02–2.19)
The data are presented as adjusted odds ratios (95% confidence interval).
Table 2 Comparison of women with and without hypertension and diabetes respectively.
Variable Hypertension Diabetes
No (n ¼ 6016) Yes (n ¼ 763) P-value No (n ¼ 6622) Yes (n ¼ 157) P-value
Age 42.4+16.2 61.0+15.7 o0.001 44.3+16.9 64.1+15.7 o0.001
BMI (kg/m2) 23.874.0 26.174.3 o0.001 24.074.0 26.474.6 o0.001
BMI430 (kg/m2) 7.0 17.5 o0.001 7.9 19.6 o0.001
Alcohol dependency 5.8 4.6 0.15 5.8 4.3 0.42
Physical inactivity
High level 21.3 8.5 o0.001 20.1 10.5 0.003
Intermediate level 64.5 70.4 0.0014 65.2 63.8 0.73
Low level 14.2 21.1 o0.001 14.7 25.7 o0.001
Smoking status
Non-smoker 61.2 60.1 0.57 61.1 61.0 0.99
Ex-smoker 21.6 24.5 0.07 21.8 24.0 0.52
Current smoking 17.2 15.4 0.20 17.1 14.9 0.48
Results are presented as mean7SD or as %.
Snoring and daytime sleepiness as risk factors for hypertension and diabetes in women 1287associated with hypertension and diabetes when the
occurrence of daytime sleepiness is also taken into account.
The main finding in this study is that, in women, the
combination of snoring and EDS is a risk factor for both
hypertension and diabetes. EDS without snoring is associated
with diabetes but not with hypertension, while snoring
without EDS does not increase the risk of either hyperten-
sion or diabetes. The results also indicate that snoring is
harmless to diabetes and hypertension in the absence of
daytime sleepiness.
In previous epidemiologic studies designed to analyze
whether snoring is a risk factor for hypertension, the resultshave diverged, as an independent association has been
found by some8–12 but not by others.16,17 However, there are
many methodological differences between the studies. The
number of confounders that are adjusted for varies, as do
the ages of the study populations. Most importantly, in none
of these studies has the occurrence of daytime sleepiness
been taken into account. To compare our data with previous
studies, we re-calculated the multivariate analysis to
analyze the independent association between snoring and
hypertension without considering daytime sleepiness.
After adjusting for age, BMI, smoking, physical activity
and alcohol dependency, snoring was also significantly
ARTICLE IN PRESS
Table 4 Risk factor for diabetes in a population-based sample of women.
All subjects (n ¼ 6200) o50 years (n ¼ 3888) 450 years (n ¼ 2312)
BMIo20 (kg/m2) 0.69 (0.29–1.64) 2.09 (0.63–6.88) 0.29 (0.07–1.22)
20–o25 (kg/m2) 1 1 1
25–o30 (kg/m2) 1.31 (0.87–1.99) 1.71 (0.56–5.24) 1.27 (0.81–2.00)
430 (kg/m2) 2.20 (1.29–3.77) 1.13 (0.14–9.20) 2.26 (1.28–4.00)
Alcohol dependency 2.07 (0.86–4.96) 2.32 (0.66–8.28) 1.96 (0.57–6.68)
Physical activity
High level 1 1 1
Intermediate level 0.67 (0.37–1.21) 0.54 (0.21–1.40) 0.85 (0.38–1.90)
Low level 0.96 (0.49–1.90) 0.19 (0.02–1.58) 1.41 (0.59–3.39)
Smoking status
Non-smoker 1 1 1
Ex-smoker 1.07 (0.69–1.67) 1.30 (0.43–3.96) 1.02 (0.63–1.66)
Current smoker 1.13 (0.66–1.95) 1.40 (0.43–3.96) 1.14 (0.62–2.10)
EDS and snoring
No EDS or snoring 1 1 1
EDS but no snoring 2.11 (1.22–3.66) 1.22 (0.27–5.50) 2.33 (1.28–4.26)
Snoring but no EDS 1.36 (0.87–2.13) 1.21 (0.37–3.93) 1.42 (0.87–2.32)
Snoring and EDS 1.82 (0.97–3.43) Too few cases 2.00 (1.05–3.84)
The data are presented as adjusted odds ratios (95% confidence interval). The odds ratios are adjusted for age and for all the variables
in the table.
E. Lindberg et al.1288associated with hypertension in our population with an
adjusted OR of 1.4 (95% CI 1.1–1.7).
In a previous population-based, prospective study in men,
we found that snoring was a risk factor for developing
hypertension in men under the age of 50 but not in elderly
men.9 However, the data were later re-analyzed also to take
account of the occurrence of daytime sleepiness in a manner
similar to that in the present study. Also in men, only snorers
who also suffered from EDS ran an increased risk of
developing hypertension, while snoring alone (or EDS alone)
did not influence the risk.25 The theory that sleep-
disordered breathing is only a risk factor for hypertension
in symptomatic subjects is further supported by the
intervention studies published so far. In sleep clinic patients
with the diagnosis of OSAS, the reversal of sleep apnea by
continuous positive airway pressure (CPAP) was followed by
significant positive effects on blood pressure.2,5 In contrast,
CPAP does not appear to have positive effects on blood
pressure when patients with sleep apnea but without
daytime sleepiness are treated.26
The combination of snoring and EDS was a risk factor for
hypertension at all ages, but the association was more
pronounced in younger women. Moreover, in previous
community-based studies, the association between obstruc-
tive sleep apnea or snoring and hypertension decreased with
increasing age.10,27 This is also in accordance with previous
reports from clinical settings. In a sleep laboratory cohort,
sleep apnea was an independent predictor of uncontrolled
hypertension in patients aged o50 years, while in older
patients BMI was the only independent predictor.28 Bixler
et al.29 reported that sleep-disordered breathing was
associated with hypertension in both genders, but also that
the strength of this association decreased with age. Inwomeno50 years there was further a significant interaction
between ‘‘snoring and EDS’’ and BMI430 for hypertension
supporting the theory that the coexistence of sleep-
disordered breathing and obesity may have more wide-
spread implications for cardiovascular control and dysfunc-
tion in obese individuals.30
After adjusting for confounders, there was no significant
association between snoring without EDS and diabetes. This
might appear to be in contrast to previous prospective
studies where snoring was found to be a significant risk
factor for developing diabetes in both men13 and women.14
However, in these studies, the occurrence of daytime
sleepiness was not taken into account. When re-analyzing
our data without considering EDS, snoring is also indepen-
dently associated with diabetes (adj. OR 1.6, 95% CI
1.1–2.7).
More recently, Shin et al. reported the results of their
study designed to analyze the association between habitual
snoring and glucose and insulin metabolism in non-obese
men who performed an oral glucose tolerance test. The
habitual snorers had significantly higher glucose and insulin
levels at 2 h compared with non-habitual snorers, while
fasting glucose or insulin levels did not differ significantly
between the groups.31 Furthermore, in a population-based
sample of hypertensive men, the prevalence of obstructive
sleep apnea was significantly higher in diabetic patients
than in normoglycemic subjects, independent of central
obesity.3 In contrast, in an Italian study of obese patients,
snoring was associated with diabetes in a univariate
analysis, but in a multivariate analysis an independent
effect of snoring was only observed for hypertension.18 In
none of the cited studies, however, was the occurrence of
EDS taken into account.
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Snoring and daytime sleepiness as risk factors for hypertension and diabetes in women 1289In the limited number of surveys performed within this
area on sleep clinic cohorts, i.e. on patients referred
because of symptoms suggestive of sleep-disordered breath-
ing, the data relaying to a significant, independent relation-
ship between OSAS and diabetes are in greater agreement.
In a sleep clinic sample of males referred for suspected sleep
apnea, Strohl et al.32 found a significant relationship
between fasting insulin and the apnea-hypopnea index,
independently of BMI. The data were confirmed in a more
recent study by Meslier et al.,4 who reported a significant
relationship between sleep-disordered breathing and im-
paired glucose–insulin metabolism that was independent of
obesity and age. Furthermore, in patients with severe OSAS,
treatment with CPAP was followed by significantly improved
insulin sensitivity.6
Even though the combination of EDS and snoring, i.e. the
main symptoms of OSAS, was a risk factor for both
hypertension and diabetes, there were also differences
between the correlations to the two diseases. The associa-
tion with hypertension decreased with increasing age, while
the association with diabetes appeared to be similar in both
age groups or even more pronounced among the elderly.
Furthermore, for hypertension, only the combination of the
symptoms was independently associated with hypertension,
while snoring and EDS alone were not. For diabetes, on the
other hand, EDS was a risk factor regardless of whether or
not the subject was a snorer. One possible explanation could
be that diabetes per se gives rise to daytime sleepiness and
that sleep-disordered breathing does not influence the risk.
However, this would then be in contrast to previous reports
on significant associations between sleep-disordered breath-
ing and impaired glucose metabolism.4,6,32 The pathophy-
siology of hypertension and diabetes in sleep-disordered
breathing is not fully understood and the results obtained
here indicate that there are partly different underlying
mechanisms that contribute to the genesis of hypertension
and diabetes in OSAS, respectively. In a review of the
pathophysiology of hypertension in obstructive sleep apnea,
Richert et al.33 stated that there are three components of
importance: (1) large negative intrathoracic pressure,
(2) intermittent hypoxemia and (3) arousal from sleep. As
the severity of sleep apnea, as indicated by the maximum
intraeosophageal pressure, decreases with age,34 this might
be a possible explanation of why younger patients with sleep
apnea are more prone to develop hypertension. When it
comes to diabetes and impaired glucose metabolism, it is
known that sleep deprivation reduces insulin sensitivity35
and has a harmful impact on carbohydrate metabolism
similar to that seen in normal aging.36,37 The frequent
arousals seen in patients with OSAS might have negative
consequences on carbohydrate metabolism through similar
pathophysiologic mechanisms, such as sleep deprivation or
sleep disruption with other causes.
One limitation of the present study is the self-reported
data including the risk of recall bias and the fact that some
snoring women may not be aware that they snore. However,
when only subjects who shared a bedroom with another
person were included, this did not significantly change any
of the results. The results were adjusted for physical activity
but the method used here does only include physical activity
during leisure time. It is possible that some women were
sedentary during leisure time and physically active duringwork, or reverse. Further, hypertension and diabetes are
likely to be underestimated since blood pressure and blood
glucose were not measured, which in turn weakens the
associations. The reported figures for prevalence of hyper-
tension and diabetes are similar to recent Swedish popula-
tion studies.38,39
We conclude that, in an adult female population, the
combination of snoring and EDS is an independent risk factor
for both hypertension and diabetes, while snoring without
daytime sleepiness does not influence the risk. These
epidemiologic data also show significant differences be-
tween hypertension and diabetes in the way they interact
with the main symptoms of OSAS. These differences might
indicate that there are different underlying pathophysiolo-
gic mechanisms that contribute to the genesis of hyperten-
sion and diabetes in obstructive sleep apnea syndrome.
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